Similar Articles
881 Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
882 CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma
883 Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
884 Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era
885 Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy
886 Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2
887 Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study
888 Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites
889 Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma
890 Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA